Tyrosinaemia screening implemented in England
Tyrosinaemia screening implemented in England
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.
Prof Bob Steele, chair of the UK National Screening Committee (UK NSC), welcomes everyone to the new UK NSC website.
The UK National Screening Committee has been reviewing the way it considers ethical issues.
Advice about the use of AI for breast screening.
Professor Anne Mackie thanked everyone involved in delivering the NHS screening programmes in 2020, an exceptionally challenging year.
Find out how the UK National Screening Committee (UK NSC) reviews suggestions for modifications to NHS screening programmes.
We launched a survey in 2020 to find out your views on how the UK National Screening Committee (UK NSC) involves stakeholders and the public in its work.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
It's hard to believe it's been a year since the last annual call, but the UK National Screening Committee (UK NSC) is once again open to ideas for new population screening programmes.
In 2019, around 130 delegates attended the first national PHE Screening Inequalities Conference.
Find out about the second edition of the Screening: Evidence and Practice book by Angela Raffle, Anne Mackie and Muir Gray.